Abstract Gold nanoparticles (AuNPs) have attracted considerable interest in medical physics because their high atomic number, tunable surface chemistry, and distinctive optical properties offer opportunities in diagnostic imaging and radiation therapy. In X-ray imaging, gold may increase attenuation and potentially improve contrast, while engineered gold nanostructures can support optical and photoacoustic detection. In radiotherapy research, AuNPs are investigated as radiosensitizers that may alter local energy deposition and biological responses to ionizing radiation. These effects depend on particle size, coating, concentration, tumor uptake, radiation energy, biological environment, and experimental design. This article summarizes their properties, potential applications, and the safety, manufacturing, and translational challenges that must be addressed before widespread clinical use. Keywords: Gold nanoparticles; medical physics; cancer imaging; computed tomography; radiosensitization; radiation therapy; nanomedicine. 1. Introduction Cancer management depends on accurate detection, reliable characterization, and effective treatment while limiting harm to healthy tissues. Medical physics contributes through imaging optimization, quantitative analysis of radiation interactions, treatment planning, and quality assurance. Nanotechnology has introduced materials whose properties can be tailored at the nanoscale. Gold nanoparticles are particularly interesting because gold has a high atomic number (Z = 79), is relatively chemically stable, and can be functionalized with molecules that influence circulation, targeting, and cellular uptake. These features make AuNPs a promising research platform, although encouraging laboratory findings should not be interpreted as proof of routine clinical benefit. 2. Physical and Biological Properties of Gold Nanoparticles 2.1. Physical Properties AuNPs can be produced in different sizes and geometries, including spheres, rods, shells, and clustered structures. Their optical behavior depends on size, shape, aggregation, and the surrounding medium. Gold also attenuates X-rays, making it of interest as a potential contrast material for computed tomography (CT). Attenuation enhancement depends on concentration and the X-ray spectrum. Performance must therefore be evaluated under clinically relevant conditions rather than inferred from atomic number alone. 2.2. Surface Chemistry and Biological Behavior Gold nanoparticle surfaces can be modified with polyethylene glycol (PEG), peptides, antibodies, or other ligands. These modifications may improve colloidal stability, alter circulation time, and support interactions with selected cell types. However, tumor delivery is variable. Accumulation depends on vascular structure, particle size, surface properties, immune clearance, and individual tumor biology. Claims of selective targeting should therefore be supported by biodistribution and toxicity measurements. 3. Applications in Cancer Imaging 3.1. Computed Tomography AuNPs have been studied as potential CT contrast agents. In principle, increased local gold concentration can raise attenuation and help distinguish a region containing nanoparticles from surrounding tissues. Research applications include tumor localization, assessment of nanoparticle distribution, and image-guided treatment studies. Limitations include achieving sufficient tumor accumulation, background signal in other tissues, clearance, and delivering enough material without unacceptable toxicity. Clinical usefulness must be compared with established iodine-based contrast agents and current CT protocols. 3.2. Optical and Photoacoustic Imaging Gold nanostructures can exhibit strong optical absorption associated with localized surface plasmon resonance. This behavior depends on particle shape and composition and can be exploited in experimental optical and photoacoustic imaging. Photoacoustic systems detect ultrasound waves generated following optical absorption, potentially combining optical contrast with acoustic detection at greater tissue depths. Light penetration, heating, instrument configuration, and nanoparticle distribution remain important constraints. 3.3. Multimodal Imaging Researchers are developing nanoparticle systems that combine imaging and therapeutic functions. A single platform may support CT contrast, optical or photoacoustic tracking, and therapeutic molecule delivery. However, additional components increase complexity and require independent evaluation of stability, manufacturing reproducibility, safety, and diagnostic value. 4. Applications in Radiation Therapy 4.1. Radiosensitization Gold nanoparticles are investigated as agents that may increase radiation effects in tumor cells. Proposed mechanisms include enhanced local energy deposition near gold, secondary-electron production, changes in reactive oxygen species (ROS), and biological responses involving oxidative stress and DNA damage. The contribution of each mechanism varies with particle distribution, radiation quality and energy, cell type, and experimental conditions. Physical dose enhancement is not uniform across all energies or clinical settings, and biological effects cannot be predicted from atomic number alone. 4.2. Treatment Planning and Image Guidance If nanoparticle distribution can be measured reliably, imaging may help researchers map localization and investigate its potential contribution to radiation treatment planning. Such approaches require validated relationships between imaging signals and dose, accurate modeling of microscopic nanoparticle distribution, and evidence that treatment benefits outweigh risks. Established dose-calculation and clinical quality-assurance procedures remain essential. 4.3. Combined Therapeutic Strategies AuNPs may also be studied alongside drug delivery, photothermal therapy, or other treatment modalities. These approaches seek to combine localized heating or drug action with radiation effects. Combined treatments may introduce additional risks, requiring careful control of dose, temperature, timing, biodistribution, and normal-tissue exposure in preclinical studies. 5. Safety and Translational Challenges Biodistribution and clearance depend on particle size, coating, dose, and administration route. Potential accumulation in organs such as the liver and spleen requires particular attention. Manufacturing must be reproducible, with rigorous characterization of size distribution, aggregation, sterility, and impurities. Animal models also cannot fully reproduce human tumor biology or immune responses. Further challenges include production scale-up, regulatory requirements, cost, and compatibility with clinical workflows. Comparative clinical studies remain necessary to demonstrate meaningful benefits over established imaging agents and radiotherapy techniques. 6. Future Perspectives Future research should prioritize standardized reporting, clinically representative radiation beams, quantitative biodistribution measurements, and rigorous comparisons with current standards of care. Integrated imaging and therapy platforms may be useful when imaging signals reliably indicate nanoparticle locations and their presence produces a measurable therapeutic advantage. Progress requires collaboration among medical physicists, radiologists, radiation oncologists, chemists, biologists, and regulatory specialists. 7. Conclusion Gold nanoparticles offer a versatile research platform connecting medical physics, cancer imaging, and radiation therapy. Their X-ray attenuation and tunable optical properties support investigation as contrast agents, while their potential radiosensitizing effects motivate further preclinical research. Nevertheless, efficacy and safety depend on nanoparticle design, biological delivery, irradiation conditions, and clinical context. Further standardized preclinical and clinical studies are required before AuNP-based approaches can be considered established alternatives to current imaging or radiotherapy methods. Almustaqbal University – The First University in Iraq